RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 131 filers reported holding RELAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 13.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $314,106 | -33.0% | 37,371 | -0.0% | 0.00% | – |
| Q2 2023 | $469,049 | -24.0% | 37,374 | -0.1% | 0.00% | – |
| Q1 2023 | $616,860 | +125.4% | 37,420 | +104.1% | 0.00% | – |
| Q4 2022 | $273,671 | +0.9% | 18,330 | -24.4% | 0.00% | – |
| Q3 2022 | $271,271 | -3.5% | 24,260 | +44.6% | 0.00% | – |
| Q2 2022 | $281,000 | -47.4% | 16,782 | -1.3% | 0.00% | – |
| Q3 2021 | $534,000 | -39.6% | 17,004 | -29.9% | 0.00% | – |
| Q2 2021 | $884,000 | -72.5% | 24,240 | -73.9% | 0.00% | -100.0% |
| Q1 2021 | $3,213,000 | -21.2% | 92,930 | -5.3% | 0.00% | -50.0% |
| Q4 2020 | $4,077,000 | -80.3% | 98,092 | -79.8% | 0.00% | -81.8% |
| Q3 2020 | $20,726,000 | – | 486,611 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |